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Abstract In the last decade, autosomal recessive interleukin-
12 receptor β1 (IL-12Rβ1) deficiency, the most common
cause of Mendelian susceptibility to mycobacterial disease
(MSMD), has been diagnosed in a few children and adults
with severe tuberculosis in Iran. Here, we report three cases
referred to the Immunology, Asthma and Allergy ward at the
National Research Institute of Tuberculosis and Lung
Diseases (NRITLD) at Masih Daneshvari Hospital from
2012 to 2017 with Mycobacterium tuberculosis and non-
tuberculous mycobacteria infections due to defects in IL-
12Rβ1 but with different clinical manifestations. All three
were homozygous for either an IL-12Rβ1 missense or non-
sense mutation that caused the IL-12Rβ1 protein not to be
expressed on the cell membrane and completely abolished
the cellular response to recombinant IL-12. Our findings sug-
gest that the presence of IL-12Rβ1 deficiency should be
determined in children with mycobacterial infections at least
in countries with a high prevalence of parental consanguinity
and in areas endemic for TB like Iran.
Keywords IFN-γ . IL12RB1 . IL-12Rβ1 . IMD30 .
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Introduction
Natural human immunity to intracellular pathogens, including
opportunistic or low-virulence mycobacteria such as Bacillus
Calmette-Guérin (BCG; an attenuated Mycobacterium bovis
strain) vaccines, non-tuberculous mycobacteria (NTM) and
non-typhoid Salmonella, and/or Mycobacterium tuberculosis
(MTB), relies on the functional integrity of the interleukin (IL)
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12/23-interferon (IFN)-γ axis enabling cross-talk between
macrophages and T-lymphocytes/NK cells (Lee et al. 2011;
Mortaz et al. 2015; Prando et al. 2013). Inborn errors of im-
munity (primary immunodeficiency) such as Mendelian sus-
ceptibility to mycobacterial disease (MSMD) emphasize the
critical role of this axis in the defense against these pathogens
(Casanova and Abel 2002; Feinberg et al. 2004; Haverkamp
et al. 2014; Serour et al. 2007).
MSMD-causing mutations have been identified in eight
autosomal genes (IFNGR1, IFNGR2, STAT1, IL12B,
IL12RB1, IRF8, ISG15, and TYK2) and two X-linked genes
(IKBKG and CYBB) (Bogunovic et al. 2012; Bustamante et al.
2011; Filipe-Santos et al. 2006; Hambleton et al. 2011;
Haverkamp et al. 2014; Prando et al. 2013) resulting in im-
paired IFN-γ-mediated immunity (Casanova and Abel 2002;
de Beaucoudrey et al. 2010).
IFN-γ is essential for killing and controlling mycobacterial
infections (Casanova and Abel 2002; Lee et al. 2011).
Complete deficiency of either of the two IFN-γ receptor
chains (IFN-γR1 and IFN-γR2) or signal transducer and ac-
tivator of transcription (STAT)-1 is associated with the devel-
opment of disseminated infection in early childhood, has a
very poor prognosis, and is often fatal. Complete IL-12p40
and IL-12Rβ1 deficiencies, as well as partial IFN-γR1,
IFN-γR2, and STAT1 deficiencies, are generally associated
with a later onset disease, milder clinical infections, and a
good prognosis (Altare et al. 2001; Casanova and Abel
2002; Casanova et al. 2002; Ottenhoff et al. 2002; Özbek
et al. 2005; Reichenbach et al. 2001).
Genetic analysis of a large cohort of 220 MSMD patients
with a defective IL-12/IL-23-IFN-γ axis ranked the presence
of these mutations amongMSMD patients as IL12RB1 (40%),
IFNGR1 (39%), IL12B (9%), STAT1 (5%), IFNGR2 (4%), and
IKBKG (3%) (Casanova et al. 1995; Filipe-Santos et al. 2006;
Lee et al. 2011). In addition, IL-12Rβ1 deficiency was the first
primary immunodeficiency to be associated with pediatric tu-
berculosis in children with normal resistance to BCG and en-
vironmental mycobacteria (EM) (de Beaucoudrey et al. 2010).
IL-12Rβ1 deficiency, therefore, should probably be suspected
in any patient with an unusual infection with intracellular path-
ogens even in the absence of parental consanguinity.
IL-12Rβ1 deficiency has been diagnosed in several children
and teenagers with tuberculosis (TB). The prevalence of TB in
IL-12p40- and IL-12Rβ1-deficient patients is however lower
than BCG or NTM infection (Caragol et al. 2003; de
Beaucoudrey et al. 2010; Özbek et al. 2005). Until 2005, only
4/73 (5.5%) patients with IL-12Rβ1 or IL-12p40 deficiency had
been reported to have TB (3/54 patients with complete IL-
12Rβ1 deficiency and 1/19 patients with complete IL-12p40
deficiency) (Fieschi and Casanova 2003; Özbek et al. 2005).
BCG vaccination, and especially developing BCG disease, con-
fers a greater protection against EM disease than against TB in
IL-12Rβ1-deficient patients despite the close phylogenetic
relationship between BCG and MTB, presumably because
MTB is more virulent than EM (de Beaucoudrey et al. 2010).
Disseminated disease in children and pulmonary disease in
adults constitute two major epidemiological and clinical forms
of TB infection (Alcaïs et al. 2005). Understanding the causes
of mycobacterial infection in children and adults and finding
the driver mutations in the IL-12/IL-23-IFN-γ axis may pro-
vide a new approach for controlling the tuberculosis infections.
Here, we report threeMSMDpatients from Iran withMTB and
NTM infection due to a complete inability to produce IFN-γ in
response to IL-12 due to mutations in IL-12Rβ1.
Case reports
The three children were either born to consanguineous parents
(patients 1 and 3) or to unrelated parents (patient 2) and were
referred to the Immunology, Asthma and Allergy ward at the
National Research Institute of Tuberculosis and Lung
Diseases (NRITLD) at Masih Daneshvari Hospitals, Shahid
Beheshti University of Medical Sciences, Tehran-Iran, be-
tween January 2012 and July 2017.
Patient 1
This was an 8-year-old female born to consanguineous parents
from the center of Iran (Table 1; patient 1). She was vaccinated
with live attenuated Mycobacterium bovis BCG sub-strain
Pasteur at birth. Two months later, she developed a progres-
sive bilateral axillary adenopathy (Fig. 1a) but was discharged
without any medical intervention. At the age of 6 months, the
patient developed supraclavicular lymphadenopathy. MTB
complex was detected in drainage secretions and anti-TB
medication was initiated and continued for 6 months.
Two years later, the patient was hospitalized due to high
blood pressure, pyrexia, myalgia, cough, and severe weight
loss. Evaluation of gastric washing (GW) cultures, smear-
detected Mycobacterium, acid fast bacilli (AFB), and a poly-
merase chain reaction (PCR) test was positive for the MTB
complex and BCG. Chest radiography showed right-sided
pleural effusion and adenopathy in the para-aortic, celiac,
and mesenteric regions was seen. Both kidneys were normal
in size although evidence of abscesses on the left side was
observed by ultrasound. PCR tests for urine and pleural fluid
were also positive for BCG. An anti-TB treatment course was
started with isoniazid, rifampin, ethambutol, Klacid,
ofloxacin, and Lanoxin. Two months later, despite a negative
PCR result for the MTB complex in urine and GW, the previ-
ous t rea tment regimen was complemented wi th
clarithromycin, captopril, and IFN-γ (25 μg/m2). A few
months later, AFB was isolated following bone marrow
(BM) aspiration and an immunodeficiency was suspected.
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Eight months later, clinical manifestations (persistent
cough and dyspnea) continued to be reported despite
treatment and the patient was admitted to the hospital.
Various mycobacteriologic analyses (including sputum
smears and cultures, drug susceptibility test (DST),
PCR, and other tests) were performed. GW PCR showed
the presence of MTB complex that was isoniazid- and
rifampin-resistant. Blood tests showed a WBC of
6.1 × 103/μ l (Neu 71%; Lymph 22%; Mix 7%);
Hb10.6 g/dl; HCT33%; and the ESR was 39 mm/h in
the first hours with detected high C-reactive protein
(CRP) (78 mg/l; normal range < 10 mg/l). Liver func-
tion tests revealed an aspartate aminotransferase (AST)
of 36 u/l (normal 15–50 u/l), alanine aminotransferase
(ALT) of 10 u/l (normal 10–25 u/l), and a decreased
ALT/AST ratio. Antibody responses to tetanus and
diphtheria were normal and DHR123 and nitroblue-
tetrazolium (NBT) tests were within the normal range.
The patient was treated again with amikacin, Klacid,
cycloserine, Lanoxin, captopril, and IFN-γ (25 μg/m2).
After a few months of therapy, whole blood was collect-
ed from both the patient and her parents and the release
of IL-12 and IFN-γ from stimulated peripheral blood
mononuclear cells (PBMCs) was assessed. In brief,
PBMCs were isolated from whole blood containing
EDTA using Ficoll-Paque before being stimulated with
rhIL-12 (Gibco, Life Technologies, USA; 20 ng/ml),
rhIFN-γ (Gibco, Life Technologies, USA; 5000 UI/
ml), and/or BCG for 48 h and IFN-γ and IL-12 release
was measured by ELISA.
IFN-γ release following stimulation with BCG + rhIL-
12 was extremely low and a 100-fold lower than that
observed from PBMCs from control subjects. Although
the addition of rhIFN-γ to BCG-stimulated cells further
a
c
b
Fig. 1 Patient 1. aCTscan without contrast. Note bilateral axillary adenopathies (red arrow). b Pedigree of patient 1. c Sequencing analysis by dideoxy-
nucleotide termination method demonstrated a mutation in exon 5 of the IL-12RB1 gene using forward (left panel) and reverse (right panel) sequencing
Table 1 Genotypes and clinical phenotypes of patients with IL-12Rβ1 deficiency
Patient no. Agea/sex Age of onset (months) Kind of mycobacterial
infection
Clinical manifestations
after BCG vaccination
Involved exon/mutation
1 8.3/F 3 BCG Bilateral axillary adenopathy Exon 5/c.512A>C, Q171P
2 3.7/M 3 BCG Left axillary lymphadenopathy Exon 9/c.847C>T, R283X
3 7.3/M 5 BCG and MTB Axillary lymphadenopathy Exon 5/c.517C>T, R173W
BCG Bacille-Calmette-Guérin,MTB Mycobacterium tuberculosis
a Age at death, last follow-up, or at the time of writing this report
Immunogenetics
increased IL-12p70 release from PBMCs 4.4-fold, this
remained far less than that seen from normal healthy con-
trols (Table 2; patient 1) and was similar to that reported
in various MSMD patients (Feinberg et al. 2004). These
functional data indicated a possible genetic defect in IL-
12Rβ1.
To examine this, genomic DNA was isolated from
PBMCs by salt extraction and the IL-12Rβ1 coding exons
and flanking regions of the introns were amplified by
PCR and sequenced at Leiden University Medical
Center and a homozygous mutation in IL12RB1 exon 5,
c.512A>C, which results in the amino acid substitution
p.Q171P was identified (Fig. 1c). Both parents were het-
erozygous for this mutation. This mutation has been re-
ported previously to result in complete lack of IL-12Rβ1
protein expression on the cell membrane (Fieschi et al.
2003). To our knowledge, this is the first case from Iran
with this mutation.
Patient 2
The second case, a male born to unrelated parents and vacci-
nated with BCG at birth, was diagnosed with left axillary
lymphadenopathy at the age of 3 months (Table 1; patient 2).
Three months later, the patient developed bilateral inguinal
lymphadenopathy. This was drained and the patient
discharged. The patient was diagnosed with BCG-osis and
treated with anti-TB drugs (rifampin, isoniazid, cycloserin,
IFN-γ and, ethambutol), but despite this treatment, the patient
was re-admitted to the hospital at the age of 7 months
complaining of respiratory distress due to isoniazid use.
Histological analysis of a cervical lymph node biopsy revealed
proliferating activated histiocytes andmacrophages, inflamma-
tory cell infiltration, and a few scattered giant cells. PCR
analysis of the lymph node biopsy was positive for the MTB
complex and BCG but negative for viral infections including
EBV and CMV. On physical examination, the patient had
hepatosplenomegaly, lymphadenopathy in the para-aortic re-
gion and mesenteric roots, and bilateral axillary adenopathy.
Treatment was continued for nearly 2 years but the patient’s
general condition continued to deteriorate despite anti-TB
treatment and he was again admitted to the hospital
complaining of severe backache and abdominal ascites.
Blood analysis gave the following results: ESR 11 mm/h,
WBC 4.1 × 103/μl (Neu 39.6%; Lymph 43.7%; Mix 16.7%),
Hb 11.9 g/dl, PLT 120 × 103/μl with a low liver function test
ALT/AST ratio (310/345), and high alkaline phosphatase
(ALP) 3400 u/ml (normal range 180–1200 u/ml). A qualitative
C-reactive protein test was positive. An evaluation of the ab-
dominal cavity by imaging and by physical examination
showed moderate abdominal ascites and splenomegaly
(116 mm). Liver biopsy showed chronic hepatitis, grade
3/18, stage 2/6. This condition is seen in both viral and auto-
immune hepatitises. Plasma cell infiltration, lymphoid aggre-
gates, or follicles (seen in autoimmune hepatitis) were absent
and both liver biopsy and ascites were negative for AFB and
mycobacteria. An MSMD functional assay was conducted in
whole blood (PBMCs) and revealed a lack of response to re-
combinant IL-12 following BCG stimulation (Table 2; patient
2). Genomic sequence analysis revealed a c.847C > Tmutation
in exon 9 of the IL12RB1 gene (Fig. 2b). This defect results in a
change fromR283 to a premature stop codon (p.R283X). Both
parents were heterozygous for this mutation. This variation has
been previously reported in a single patient from the Faroe
Islands (Schejbel et al. 2011) and in two patients from Brazil
(Falcão et al. 2012). Despite anti-TB and broad-spectrum an-
tibiotic treatment, the patient’s general condition continued to
deteriorate and the patient died a year after the detection of his
immunodeficiency status at the age of 3 years and 7 months.
Table 2 In vitro production of
IFN-γ and IL-12p70 following
stimulation in three IL-12Rβ1-
deficient patients and healthy
control subjects
Cytokine detected Stimulusa Patient 1 Patient 2 Patient 3 Healthy controls
Mean ± SEM
n = 6
IFN-γ (pg/ml) Medium 0 0 1.8 37.4 ± 12.4
BCG 47.2 15.4 35.04 1059.9 ± 136.9
BCG + rhIL-12 80.24 16.9 42.04 16,703 ± 2036
SI 1.7 1.1 1.2 16.6 ± 2.4
IL-12p70 (pg/ml) Medium 0.9 17.1 0.16 2.7 ± 0.8
BCG 49.8 64.8 77.5 75.8 ± 7.8
BCG + rhIFN-γ 219.1 272.1 410.7 700.1 ± 89.9
SI 4.4 4.2 5.3 9.5 ± 1.2
a Stimulation status: unstimulated (medium), stimulated with BCG alone, stimulated with BCG plus recombinant
IL-12p70 (20 ng/ml), or stimulated with BCG plus recombinant IFN-γ (5000 UI/ml)
SI stimulation index (BCG + cytokine/BCG), SEM standard error of the mean
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Patient 3
The third patient was a 7-year-old male vaccinated with BCG at
birth that developed axillary lymphadenopathy at 5 months of
age (Table 1; patient 3). The family had no history of TB or
exposure toMTB. The patient was referred to the hospital due to
an abscess in the thoracic cavity at 15 months associated with
high fever, cough, and anemia and with abdominal ascites.
Whole blood analysis gave the following results: WBC
3.9 × 103/μl (Neu 0%; Lymph 48%; Mono 49%; Mix 3%),
Hb 6.3 g/dl, platelets 95 × 103/μl, ESR 135 mm/h, and CRP
24 mg/lit. BM aspiration was hypocellular. An evaluation of the
abdominal cavity by imaging and by physical examination
showed abdominal ascites, splenomegaly, and lymphadenopa-
thy in the para-aortic, mesenteric, and celiac regions. A tuber-
culin skin test was negative and serum levels of IgG and IgE
were elevated. GW was positive for mycobacteria on
Lowenstein-Jensen medium. The lymphocyte transformation
test (LTT) for BCG was 2.1 (normal levels ≥ 2.5) and an NBT
test was normal. Based on the physical analysis, laboratory data,
and clinical signs, the patient underwent MSMD functional
evaluation. Ayear and a half later, despite treatment with rifam-
pin, isoniazid, ethambutol, and clarithromycin, the patient was
re-admitted to the hospital due to backache, abdomen disten-
sion, and ascites. Radiologic analysis showed splenomegaly
(126 mm). The ascites smear test was negative for AFB.
Four months later, the blood culture was positive for
Kingella species and blood tests revealed the following results:
WBC 7.05 × 103/μl (Neu 72.3%; Lymph 10.1%;Mono 11.9%;
Eos 5.4%; Baso 0.3%), Hb 12.4 g/dl, and PLT 241 × 103/μl
and the CD4/CD8 ratio was decreased compared to control
levels (9/40). Serological assays and PCR for HIV were both
negative. Thus, levofloxacin and IFN-γ were added to the
treatment regimen (rifampin, isoniazid, ethambutol, amikacin).
However, at 5.5 years of age, the general condition of the
patient deteriorated severely and the patient was again admitted
to the hospital complaining of seizure and experienced respi-
ratory distress, scrotal edema, severe backache, abdominal as-
cites, and distension during the hospitalization. Complete
blood analysis gave the following results: WBC 6.8 × 103/μl
(Neu 79%; Lymph 13%; Mix 8%), Hb 10.7 g/dl, and PLT
142 × 103/μl and CRP was 61 mg/l. A low liver function test
ALT/AST ratio (15/20) was observed.Multiple brain abscesses
and cerebritis were seen by MRI (Fig. 3a–c), probably due to
BCG-osis, and peripheral edema in the cerebrium was ob-
served by computed tomography. The BACTEC test result
for ascites and TB PCR for synovial fluid were all negative
for AFB and TB. One year later, the brain abscesses were
PCR-positive for TB that was rifampin-resistant.
Progression from localized disease into disseminated infec-
tion suggested an underlying immunodeficiency and a genetic
and functional analysis of the IL-12/IL-23/IFN-γ loop was
performed. Functional analysis revealed possible defects in
the IL-12Rβ1 (Table 2; patient 3) and genetic testing revealed
the homozygous IL12RB1mutation c.517C>T in exon 5 (Fig.
3e). This variation leads to an R173W amino acid change.
Both parents of the patient were found to be heterozygous
for this mutation. The R173W mutation has been previously
reported in patients from Brazil, Venezuela, Poland (de
Beaucoudrey et al. 2010), and Iran (Boisson-Dupuis et al.
2011). The previously reported Iranian patient had a history
of PTB and cutaneous leishmaniasis (Boisson-Dupuis et al.
2011). To our knowledge, this is only the second patient in
Iran reported with this mutation.
b
a
Fig. 2 Patient 2. a Pedigree of patient 2. b Sequencing analysis by dideoxy-nucleotide termination method. A mutation in exon 9 of the IL12RB1 gene
was found in this patient; left and right panels indicate results for forward and reverse sequencing
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Discussion
In young children, TB is often disseminated due to early,
hematogenous spread of the Mycobacterium after primary
pulmonary infection (Alcaïs et al. 2005). Clinical TB has
now been described in a number of patients with IL-12/
IL-23/IFN-γ system defects (Ottenhoff et al. 2005) and
may result from autosomal recessive IL-12Rβ1 deficien-
cy, in at least some children (Boisson-Dupuis et al. 2011).
The present study reports three Iranian children with com-
plete IL-12Rβ1 deficiency confirming previous studies in
Iranian patients with an IL-12Rβ1 defect (Azam
Sarrafzadeh et al. 2016; Boisson-Dupuis et al. 2011; de
Beaucoudrey et al. 2010; Fieschi et al. 2003; Parvaneh
et al. 2015; Tabarsi et al. 2011).
In the present study, we screened for IL-12Rβ1 muta-
tions in suspected patients with MTB infection and report-
ed three homozygous mutations: Q171P, R283X, and
R173W. Patients 1 and 2 are the first reports of children
with Mycobacterium infection due to IL-12Rβ1 deficien-
cy in Iran. Patient 3, with an R173W mutation, is only the
second child reported in Iran with this particular mutation
(Boisson-Dupuis et al. 2011) and MTB infection.
Interestingly, all three of the IL-12Rβ1-deficient patients
reported here had been vaccinated with BCG and had
developed BCG disease.
However, this deficiency is probably not unique to chil-
dren, as a young adult case with TB and IL-12Rβ1 deficiency
has also been identified in Iran (Tabarsi et al. 2011). The
increasing reports of Iranian patients with defects in the IL-
12/IL-23/IFN-γ axis (Azam Sarrafzadeh et al. 2016; Boisson-
Dupuis et al. 2011; de Beaucoudrey et al. 2010; Mansouri
et al. 2005; Parvaneh et al. 2015), particularly in areas with a
high prevalence of parental consanguinity and a very low
prevalence of HIV (less than 0.15%) (Boisson-Dupuis et al.
2011), suggest that screening for defects in this pathway
should be considered in all cases. Thus, it will be important
to define the prevalence of IL-12Rβ1 deficiency and related
disorders among children and adults with severe TB. This is
especially important in countries where the disease is endemic
such as Iran (Tabarsi et al. 2011).
Mandatory screening for IL-12Rβ1 mutations that cause a
defective IL-12/IL-23/IFN-γ axis would not only improve the
quality of patient care but also increase the safety monitoring
for potential complications including infectious diseases in
these subjects. A global registry of patients with genetic de-
fects in the IL-12/IL-23/IFN-γ axis such as that available at
www.lovd.nl/IL12RB1 for IL-12Rβ1 defects, and that are al-
so available for most other genes that cause MSMD, together
with awareness of these immunodeficiencies prior to BCG
vaccination will improve the health and quality of care for
these patients.
a b c
e
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Fig. 3 Patient 3. Cerebral abscesses. a Axial T1-weighted spin MRI
image without contrast. There is a hypo-intense lesion (red arrow)
with an iso-intense capsule (green arrow) posterior to temporal horn
of the right lateral ventricle. The lesion has compressed the temporal
horn. b Axial T1-weighted spine MRI image with contrast. The cap-
sule demonstrates marked enhancement (red arrow). c Axial T2-
weighted spine MRI image. The abscess is hyper-intense (red arrow).
The capsule is iso-intense (green arrow) and the vasogenic edema
surrounding the lesion (blue arrow) is also hyper-intense. d
Pedigree of patient 3. e Sequencing analysis by dideoxy-nucleotide
termination method demonstrated a mutation in exon 5 of the
IL12RB1 gene using forward (left panel) and reverse (right panel)
sequencing
Immunogenetics
Funding This study received financial support from National Research
Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti
University of Medical Sciences, Tehran, Iran.E .Mortaz was suported by
National Institute for Medical Research Development (NIMAD) grant
number 958274.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval Our study was performed according to the ethical
standards issued by the COPE.
Informed consent Informed consent was obtained from all individual
participants included in the study.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Alcaïs A, Fieschi C, Abel L, Casanova J-L (2005) Tuberculosis in chil-
dren and adults. J Exp Med 202:1617–1621
Altare F et al (2001) Interleukin-12 receptor β1 deficiency in a patient
with abdominal tuberculosis. J Infect Dis 184:231–236
Azam Sarafzadeh S, Mahloojirad M, Nourizadeh M, Casanova J-L,
Pourpak Z, Bustamante J, Moin M (2016) Mendelian susceptibility
to mycobacterial disease due to IL-12Rβ1 deficiency in three
Iranian children. Iran J Public Health 45:249
Bogunovic D et al (2012) Mycobacterial disease and impaired IFN-γ
immunity in humans with inherited ISG15 deficiency. Science
337:1684–1688
Boisson-Dupuis S et al (2011) IL-12Rβ1 deficiency in two of fifty chil-
dren with severe tuberculosis from Iran, Morocco, and Turkey.
PLoS One 6:e18524
Bustamante J et al (2011) Germline CYBB mutations that selectively
affect macrophages in kindreds with X-linked predisposition to tu-
berculous mycobacterial disease. Nat Immunol 12:213–221
Caragol I et al (2003) Clinical tuberculosis in 2 of 3 siblings with
interleukin-12 receptor β1 deficiency. Clin Infect Dis 37:302–306
Casanova J-L, Abel L (2002) Genetic dissection of immunity to
mycobacteria: the human model. Annu Rev Immunol 20:581–620
Casanova J-L, Jouanguy E, Lamhamedi S, Blanche S, Fischer A (1995)
Immunological conditions of children with BCG disseminated in-
fection. Lancet 346:581
Casanova J-L, Mansoori D, Fieschi C, Picard C, Dupuis S (2002)
Inherited disorders of the interleukin-12-interferon gamma axis:
Mendelian predisposition to mycobacterial disease in man.
Tanaffos 1:9–25
de Beaucoudrey L et al (2010) Revisiting human IL-12Rβ1 deficiency: a
survey of 141 patients from 30 countries. Medicine 89:381
Falcão ACAM, Marques PTL, Santos AR, Oliveira JB (2012)
Disseminated histoplasmosis caused by Il12rb1 gene mutations in
two Brazilian siblings. J Clin Immunol 32:405
Feinberg J et al (2004) Bacillus Calmette Guérin triggers the IL-12/IFN-γ
axis by an IRAK-4-and NEMO-dependent, non-cognate interaction
between monocytes, NK, and T lymphocytes. Eur J Immunol 34:
3276–3284
Fieschi C, Casanova JL (2003) Mini-review the role of interleukin-12 in
human infectious diseases: only a faint signature. Eur J Immunol 33:
1461–1464
Fieschi C et al (2003) Low penetrance, broad resistance, and favorable
outcome of interleukin 12 receptor β1 deficiency. J Exp Med 197:
527–535
Filipe-Santos O et al. Inborn errors of IL-12/23-and IFN-γ-mediated im-
munity: molecular, cellular, and clinical features. In: Seminars in
immunology, 2006. vol 6. Elsevier, pp 347–361
Hambleton S et al (2011) IRF8 mutations and human dendritic-cell im-
munodeficiency. N Engl J Med 365:127–138
Haverkamp MH, van de Vosse E, van Dissel JT (2014) Nontuberculous
mycobacterial infections in children with inborn errors of the im-
mune system. J Inf 68:S134–S150
Lee W-I, Huang J-L, Yeh K-W, Jaing T-H, Lin T-Y, Huang Y-C, Chiu C-
H (2011) Immune defects in active mycobacterial diseases in pa-
tients with primary immunodeficiency diseases (PIDs). J Formos
Med Assoc 110:750–758
Mansouri D et al (2005) Inherited disorders of the IL-12-IFN-γ axis in
patients with disseminated BCG infection. Eur J Pediatr 164:753–757
Mortaz E et al (2015) Interaction of pattern recognition receptors with
Mycobacterium tuberculosis. J Clin Immunol 35:1–10
Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, HoeveMA, Sanal O,
van Dissel JT (2002) Genetics, cytokines and human infectious dis-
ease: lessons from weakly pathogenic mycobacteria and salmonel-
lae. Nat Genet 32:97–105
Ottenhoff TH, Verreck FA, HoeveMA, van de Vosse E (2005) Control of
human host immunity to mycobacteria. Tuberculosis 85:53–64
Özbek N et al (2005) Interleukin-12 receptor β1 chain deficiency in a
child with disseminated tuberculosis. Clin Infect Dis 40:e55–e58
Parvaneh N et al (2015) Impaired in-vitro responses to IL-12 and IFN-γ
in Iranian patients with Mendelian susceptibility to mycobacterial
disease. Allergol Immunopathol (Madr) 43:456–460
Prando C et al (2013) Inherited IL-12p40 deficiency: genetic, immuno-
logic, and clinical features of 49 patients from 30 kindreds. Medicine
92:109
Reichenbach J, Rosenzweig S, Döffinger R, Dupuis S, Holland SM,
Casanova J-L (2001) Mycobacterial diseases in primary immunode-
ficiencies. Curr Opin Allergy Clin Immunol 1:503–511
Schejbel L et al (2011) Combined IL-12 receptor and IgA deficiency in an
adult man intestinally infested by an unknown, non-cultivable
Mycobacterium. Scand J Immunol 74:548–553
Serour F, Mizrahi A, Somekh E, Feinberg J, Picard C, Casanova J-L,
Dalal I (2007) Analysis of the interleukin-12/interferon-γ pathway
in children with non-tuberculous mycobacterial cervical lymphade-
nitis. Eur J Pediatr 166:835–841
Tabarsi P et al (2011) Lethal tuberculosis in a previously healthy adult
with IL-12 receptor deficiency. J Clin Immunol 31:537–539
Immunogenetics
